| |
Latest 10 SEC filings (by transaction date) for NBIX within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 15/24 | Mar 14/24 | Benevich Eric | Direct Ownership | Non-Qualified Stock Option | M - Exercise or conversion exempt under rule 16b-3 | -69,521 | $81.05 |
Mar 15/24 | Mar 14/24 | Benevich Eric | Direct Ownership | Non-Qualified Stock Option | M - Exercise or conversion exempt under rule 16b-3 | -5,479 | $79.02 |
Mar 15/24 | Mar 14/24 | Benevich Eric | Direct Ownership | Common Stock | S - Open market or private sale | -69,521 | $139.38 |
Mar 15/24 | Mar 14/24 | Benevich Eric | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 69,521 | $81.05 |
Mar 15/24 | Mar 14/24 | Benevich Eric | Direct Ownership | Common Stock | S - Open market or private sale | -5,479 | $139.38 |
Mar 15/24 | Mar 14/24 | Benevich Eric | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 5,479 | $79.02 |
Mar 15/24 | Mar 14/24 | Morrow George J | Direct Ownership | Non-Qualified Stock Option | M - Exercise or conversion exempt under rule 16b-3 | -20,000 | $39.79 |
Mar 15/24 | Mar 14/24 | Morrow George J | Direct Ownership | Non-Qualified Stock Option | M - Exercise or conversion exempt under rule 16b-3 | -20,000 | $39.79 |
Mar 15/24 | Mar 14/24 | Morrow George J | Direct Ownership | Common Stock | S - Open market or private sale | -20,000 | $139.41 |
Mar 15/24 | Mar 14/24 | Morrow George J | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 20,000 | $39.79 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for NBIX within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 15/24 | Mar 14/24 | Benevich Eric | Direct Ownership | Non-Qualified Stock Option | M - Exercise or conversion exempt under rule 16b-3 | -69,521 | $81.05 |
Mar 15/24 | Mar 14/24 | Benevich Eric | Direct Ownership | Non-Qualified Stock Option | M - Exercise or conversion exempt under rule 16b-3 | -5,479 | $79.02 |
Mar 15/24 | Mar 14/24 | Benevich Eric | Direct Ownership | Common Stock | S - Open market or private sale | -69,521 | $139.38 |
Mar 15/24 | Mar 14/24 | Benevich Eric | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 69,521 | $81.05 |
Mar 15/24 | Mar 14/24 | Benevich Eric | Direct Ownership | Common Stock | S - Open market or private sale | -5,479 | $139.38 |
Mar 15/24 | Mar 14/24 | Benevich Eric | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 5,479 | $79.02 |
Mar 15/24 | Mar 14/24 | Morrow George J | Direct Ownership | Non-Qualified Stock Option | M - Exercise or conversion exempt under rule 16b-3 | -20,000 | $39.79 |
Mar 15/24 | Mar 14/24 | Morrow George J | Direct Ownership | Non-Qualified Stock Option | M - Exercise or conversion exempt under rule 16b-3 | -20,000 | $39.79 |
Mar 15/24 | Mar 14/24 | Morrow George J | Direct Ownership | Common Stock | S - Open market or private sale | -20,000 | $139.41 |
Mar 15/24 | Mar 14/24 | Morrow George J | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 20,000 | $39.79 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Cerevel Therapeutics Hold (OQ:CERE) |
Vertex Pharmaceuticals (OQ:VRTX) |
Regeneron Pharmaceuticals (OQ:REGN) |